A Randomized Phase III Trial of Chemo-Immunotherapy vs Immunotherapy Alone for the Vulnerable Older Adult With Advanced Non-Small Cell Lung Cancer: The ACHIEVE Study
NCT06096844 · RECRUITING · Phase 3
ReadTheTrial indexes 4 studies for Advanced Lung Non Small Cell Carcinoma. The most common development stage is Phase 2 (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
4 clinical trials found for Advanced Lung Non Small Cell Carcinoma.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 2 | 50% |
| Phase 3 | 1 | 25% |
| Phase 1 | 1 | 25% |
There are 4 clinical trials listed for Advanced Lung Non Small Cell Carcinoma. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Advanced Lung Non Small Cell Carcinoma trials are distributed across: Phase 2 (2), Phase 3 (1), Phase 1 (1).